PRL and arthritic joint disease: Recombinant PRL regulates gene expression pathways that control inflammation, proliferation, and cell survival in synoviocytes, suggesting that NR4A2-induced PRL may elicit similar autocrine responses that may subsequently impact arthritis progression.